Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Pace

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2005
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatmentLeonardo Pace, Michele Klain, Carmine Albanese, et al.
European Journal of Radiology|December 17, 2013
Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissuesLeonardo Pace, Emanuele Nicolai, Angelo Luongo, et al.
AJR. American Journal of Roentgenology|October 23, 2008
Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesionsMassimo Imbriaco, Maria Grazia Caprio, Gennaro Limite, et al.
Frontiers in Endocrinology|April 2, 2019
Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial TreatmentMichele Klain, Leonardo Pace, Emilia Zampella, et al.
Nuclear Medicine and Biology|March 26, 2013
Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMPGiovanni Storto, Rosj Gallicchio, Teresa Pellegrino, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 8, 2017
Evaluation of metabolic response with <sup>18</sup>F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumorsSabrina Segreto, Rosa Fonti, Margaret Ottaviano, et al.
Bone|January 26, 2006
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastasesGiovanni Storto, Michele Klain, Gaetano Paone, et al.
AJR. American Journal of Roentgenology|May 30, 2002
Dual-phase versus single-phase helical CT to detect and assess resectability of pancreatic carcinomaMassimo Imbriaco, Alec J Megibow, Luigi Camera, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myelomaRosa Fonti, Silvana Del Vecchio, Antonella Zannetti, et al.
World Journal of Gastroenterology|April 8, 2011
Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging?Pier Paolo Mainenti, Delfina Iodice, Sabrina Segreto, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2005
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatmentLeonardo Pace, Michele Klain, Carmine Albanese, et al.
European Journal of Radiology|December 17, 2013
Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissuesLeonardo Pace, Emanuele Nicolai, Angelo Luongo, et al.
AJR. American Journal of Roentgenology|October 23, 2008
Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesionsMassimo Imbriaco, Maria Grazia Caprio, Gennaro Limite, et al.
Frontiers in Endocrinology|April 2, 2019
Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial TreatmentMichele Klain, Leonardo Pace, Emilia Zampella, et al.
Nuclear Medicine and Biology|March 26, 2013
Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMPGiovanni Storto, Rosj Gallicchio, Teresa Pellegrino, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 8, 2017
Evaluation of metabolic response with <sup>18</sup>F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumorsSabrina Segreto, Rosa Fonti, Margaret Ottaviano, et al.
Bone|January 26, 2006
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastasesGiovanni Storto, Michele Klain, Gaetano Paone, et al.
AJR. American Journal of Roentgenology|May 30, 2002
Dual-phase versus single-phase helical CT to detect and assess resectability of pancreatic carcinomaMassimo Imbriaco, Alec J Megibow, Luigi Camera, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myelomaRosa Fonti, Silvana Del Vecchio, Antonella Zannetti, et al.
World Journal of Gastroenterology|April 8, 2011
Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging?Pier Paolo Mainenti, Delfina Iodice, Sabrina Segreto, et al.
Pageof 7